Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Atherosclerosis. 2022 Dec 19;374:44–54. doi: 10.1016/j.atherosclerosis.2022.12.003

Table 1.

Summary of miRNAs involved in CVDs.

CVD miRNA Target genes Biological role of miRNA Ref.
Atherosclerosis miR-10a MAP3K7 and BTRC Reduced expression of endothelial adhesion molecules and proinflammatory cytokines 12
miR-126 Dlk1 Enhanced proliferation of endothelial cells 15
miR-155 Hbp1 Increased lipid uptake, synthesis of ROS, and foam cell formation 17
miR-33a ABCA1 Reduced cholesterol efflux and increased foam cell formation 18
miR-145 KLF5 Prevents neointima formation 19
miR-362 ADAMTS1 Prevents vascular smooth muscle cell proliferation and migration into the intima 22
Myocardial infarction (MI) miR-1 Kcnj2 and Gja1 Decreased cardiac conductivity and induction of arrhythmias 24
miR-433 Azin1 Activates TGF-β signaling to induce cardiac fibrosis 25
miR-24 Gata2 and Pak4 Induction of apoptosis of endothelial cells and reduced neovascularization of the ischemic myocardium 26
miR-134 Kdm2a Repression of myocardial angiogenesis after MI 27
Hypertension and hypertensive heart disease miR-181a and miR-663 REN Downregulation may lead to higher renin expression in the renal cortex of hypertensive patients 29
miR-143 ACE2 Downregulation may enhance ACE2 expression in the arteries of hypertensive patients 30
miR-26 Gata4 Prevents pressure overload-induced cardiac hypertrophy 31
miR-217 Pten Promotes cardiac hypertrophy via AKT pathway activation 32
miR-214 Sirt3 Enhances mitochondrial dysfunction and cardiac hypertrophy 33

CVD: cardiovascular disease; ROS: reactive oxygen species; MI: myocardial infarction